Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary …
K Chatzistamatiou, T Moysiadis, E Angelis… - Archives of gynecology …, 2017 - Springer
Purpose The purpose of the presented PIPAVIR (persistent infections with human
papillomaviruses; http://www. pipavir. com) subanalysis is to assess the performance of high …
papillomaviruses; http://www. pipavir. com) subanalysis is to assess the performance of high …
Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile
C Ferreccio, MI Barriga, M Lagos… - … journal of cancer, 2013 - Wiley Online Library
Cervical cancer mortality in Chile is four times higher than in developed countries. We
compared the accuracy of human papillomavirus (HPV) DNA testing and conventional …
compared the accuracy of human papillomavirus (HPV) DNA testing and conventional …
[HTML][HTML] Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in …
H Xu, A Lin, X Shao, W Shi, Y Zhang, W Yan - Oncotarget, 2016 - ncbi.nlm.nih.gov
Currently, clinical data for primary HPV screening alone are lacking in China. Here, we
evaluate cervical cancer screening with primary HPV genotyping, as well as possible future …
evaluate cervical cancer screening with primary HPV genotyping, as well as possible future …
Clinical performance of hrHPV primary screening using vaginal versus cervical samples to detect high-grade intraepithelial lesions
J King, YN Flores, J Meneses-León… - Cancer Prevention …, 2023 - AACR
High-risk human papillomavirus (hrHPV) testing is now the most recommended primary
method for cervical cancer screening worldwide. Clinician-collected cervical sampling …
method for cervical cancer screening worldwide. Clinician-collected cervical sampling …
Use of Cytology, E6/E7 mRNA, and p16INK4a–Ki-67 to Define the Management of Human Papillomavirus (HPV)–Positive Women in Cervical Cancer Screening
D Gustinucci, PG Rossi, E Cesarini… - American journal of …, 2016 - academic.oup.com
Objectives: We measured the accuracy of p16INK4a-Ki67 (CINtec PLUS, Roche, Mannheim,
Germany), and E6/E7mRNA (types 16/18/31/33/45 NucliSENS easyQ, bioMérieux, Boxtel …
Germany), and E6/E7mRNA (types 16/18/31/33/45 NucliSENS easyQ, bioMérieux, Boxtel …
The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening
F Song, H Du, C Wang, X Huang, X Qu… - Journal of medical …, 2021 - journals.sagepub.com
Objective The performance of Cobas4800 cycle threshold value (Ct-value, reflecting viral
load) combined with human papillomavirus (HPV) 16/18 genotyping was explored as a …
load) combined with human papillomavirus (HPV) 16/18 genotyping was explored as a …
Impact of possibly oncogenic high-risk human papillomavirus (HPV) types in triage for ASC-US cervical cytology results
EJ Amarosa, RL Winer, KJ Hong… - Journal of Lower Genital …, 2015 - journals.lww.com
Objective Current guidelines recommend including 13 or 14 high-risk human papillomavirus
(HPV) types for triage of atypical squamous cells of undetermined significance (ASC-US) …
(HPV) types for triage of atypical squamous cells of undetermined significance (ASC-US) …
Randomized implementation of a primary human Papillomavirus testing–based Cervical cancer screening protocol for women 34 to 69 years in Norway
M Nygård, B Engesæter, PE Castle, JM Berland… - … Biomarkers & Prevention, 2022 - AACR
Background: Cervical cancer screening programs are facing a programmatic shift where
screening protocol based on human papillomavirus testing (HPV-Screening protocol) is …
screening protocol based on human papillomavirus testing (HPV-Screening protocol) is …
Clinical performance of the BD onclarity extended genotyping assay for the management of women positive for human papillomavirus in cervical cancer screening
KD Volesky, S Magnan, MH Mayrand, SD Isidean… - … Biomarkers & Prevention, 2022 - AACR
Background: Among women whose cervical specimens tested positive for high-risk human
papillomaviruses (hrHPV) via the Hybrid Capture 2 assay in the Canadian Cervical Cancer …
papillomaviruses (hrHPV) via the Hybrid Capture 2 assay in the Canadian Cervical Cancer …
Stratifying HPV‐positive women for CIN3+ risk after one and two rounds of HPV‐based screening
NJ Veldhuijzen, NJ Polman… - … journal of cancer, 2017 - Wiley Online Library
A main challenge of human papilloma (HPV)‐based screening for cervical cancer is to
adequately identify HPV‐positive women at highest risk of cervical intraepithelial neoplasia …
adequately identify HPV‐positive women at highest risk of cervical intraepithelial neoplasia …